These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28489780)

  • 1. Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.
    Sun X; Zhangyuan G; Shi L; Wang Y; Sun B; Ding Q
    Medicine (Baltimore); 2017 May; 96(19):e6860. PubMed ID: 28489780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and prognostic significance of cyclin D1 amplification in patients with breast cancer: a meta-analysis.
    He Q; Wu J; Liu XL; Ma YH; Wu XT; Wang WY; An HX
    J BUON; 2017; 22(5):1209-1216. PubMed ID: 29135104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies.
    Li Y; Wei J; Xu C; Zhao Z; You T
    PLoS One; 2014; 9(4):e94508. PubMed ID: 24728073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
    Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
    Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Cyclin D1 Expression in Renal Cell Carcinoma: a Systematic Review and Meta-analysis.
    Li Z; Liu J; Zhang X; Fang L; Zhang C; Zhang Z; Yan L; Tang Y; Fan Y
    Pathol Oncol Res; 2020 Jul; 26(3):1401-1409. PubMed ID: 31748879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and clinicopathological significance of Cks1 in cancer: Evidence from a meta-analysis.
    Zhang Y; Chen Y; You F; Li W; Lang Z; Zou Z
    J Cell Physiol; 2019 Aug; 234(8):13423-13430. PubMed ID: 30605238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis.
    Huang W; Ran R; Shao B; Li H
    Breast Cancer Res Treat; 2019 Nov; 178(1):17-33. PubMed ID: 31359214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and Prognostic Significance of CBX3 Expression in Human Cancer: a Systematic Review and Meta-analysis.
    Lin H; Zhao X; Xia L; Lian J; You J
    Dis Markers; 2020; 2020():2412741. PubMed ID: 33273987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic role of SIRT1 in breast cancer patients: a meta-analysis.
    Cao YW; Li YC; Wan GX; Du XM; Li F
    Int J Clin Exp Med; 2015; 8(1):616-24. PubMed ID: 25785036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and clinicopathological significance of fibrinogen-to-albumin ratio (FAR) in patients with breast cancer: a meta-analysis.
    Wang Z; Shen X
    World J Surg Oncol; 2024 Aug; 22(1):220. PubMed ID: 39182155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
    Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
    PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis.
    Guo Y; Yu P; Liu Z; Maimaiti Y; Chen C; Zhang Y; Yin X; Wang S; Liu C; Huang T
    PLoS One; 2017; 12(4):e0174843. PubMed ID: 28394898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and updated meta-analysis.
    Kang J; Jung H; Kim H
    Medicine (Baltimore); 2024 Jan; 103(3):e37016. PubMed ID: 38241547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of cyclin D1 expression in the survival of cancer patients: A meta-analysis.
    Moradi Binabaj M; Bahrami A; Khazaei M; Ryzhikov M; Ferns GA; Avan A; Mahdi Hassanian S
    Gene; 2020 Feb; 728():144283. PubMed ID: 31838249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
    Petrelli F; Viale G; Cabiddu M; Barni S
    Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
    Zhang B; Xie Z; Li B
    Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study.
    Lundgren C; Ahlin C; Holmberg L; Amini RM; Fjällskog ML; Blomqvist C
    Acta Oncol; 2015 Apr; 54(4):538-44. PubMed ID: 25327158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinicopathological significance of SR-B1 in solid tumors: A meta-analysis.
    Wang M; Chao C; Luo G; Wang B; Zhan X; Di D; Qian Y; Zhang X
    Pathol Res Pract; 2020 Apr; 216(4):152849. PubMed ID: 32057516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.